CNA CNA Financial (CNA) Insider Trading, Ownership & Congress Trades
Insurance · Fire, marine & casualty insurance · CIK 0000021175
Form 144 · 2
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about CNA
Insiders, 180 days
-$1.6M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.6M
2 notices
CNA Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CNA FINANCIAL CORP insiders sold a net $1.6M of stock across 51 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Mar 17, 2025.
- The trade is 33.3% of the 68,032 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: EVP & CAO Franzetti Daniel Paul sold about $1.2M of CNA on Aug 4, 2026, the largest insider sale at the company since 2024; 1 other insider sold within 30 days.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 20, 2025.
- The trade is 31.3% of the 26,446 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: EVP, Chief Risk & Rein Off James Mark Steven sold about $439.7K of CNA on Aug 4, 2026; 1 other insider sold within 30 days.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 45.2% of the 7,277 shares held after it.
- No other insider sold within 30 days.
Insider activity: SVP & General Counsel Neuenschwander Jeffrey John sold about $151.1K of CNA on Mar 19, 2026.Context
- 13 earlier Form 4 trades (code P or S) here by this insider (2 buys, 11 sales), the last on Dec 1, 2025.
- The trade is 0.9% of the 661,838 shares held after it.
- No other insider sold within 30 days.
Insider activity: Executive Chairman Robusto Dino sold about $297.6K of CNA on Jan 2, 2026.Context
- 12 earlier Form 4 trades (code P or S) here by this insider (2 buys, 10 sales), the last on Nov 3, 2025.
- The trade is 0.9% of the 668,088 shares held after it.
- No other insider sold within 30 days.
Insider activity: Executive Chairman Robusto Dino sold about $293.2K of CNA on Dec 1, 2025.51 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$1.6M over 180 days
-$1.6M over 90 days
more than 60% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
-2.0% year over year
below 86% of Insurance
Margin
81.0% net margin
more than 95% of Insurance
Buybacks
$36.0M repurchased, FY to 2026-06-30
below 77% of Insurance
Short interest
18.5% of the float short (float per yahoo 2026-10-26) · 5.0 days to cover · settled 2026-09-30
below 79% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CNA
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+14.7%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CNA: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in CNA
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CNA planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
DANIEL FRANZETTI
Filed 2026-08-04
$1.2M
MARK JAMES
Filed 2026-08-04
$439.8K
Executive pay vs shareholder return · Dino Robusto
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$16.1M
$17.5M
$4.9M
+25%
+69%
2022
$15.1M
$14.9M
$4.1M
+18%
+56%
2021
$14.2M
$16.2M
$3.6M
+13%
+30%
2020
$11.5M
$9.9M
$4.0M
-5%
+7%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.6M sold by insiders over 180 days, $1.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
CNA financials
Revenue growth
-2.0%
XBRL, annual
Net margin
81.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$15.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CNA
| FY Dec 2025 | $15.0B |
| FY Dec 2024 | $14.3B |
| FY Dec 2023 | $13.3B |
| FY Dec 2022 | $11.9B |
| FY Dec 2021 | $11.9B |
| Jun 2026 | $3.8B |
| Mar 2026 | $3.7B |
| Dec 2025 | $3.8B |
| Sep 2025 | $3.8B |
| Jun 2025 | $3.7B |
| Mar 2025 | $3.6B |
| Dec 2024 | $3.7B |
| Sep 2024 | $3.6B |
At each fiscal year end
Single quarter
Net margin, TTM
+8.2%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CNA
| FY Dec 2025 | +8.5% |
| FY Dec 2024 | +6.7% |
| FY Dec 2023 | +9.1% |
| FY Dec 2022 | +5.7% |
| FY Dec 2021 | +9.9% |
| Jun 2026 | +8.4% |
| Mar 2026 | +5.7% |
| Dec 2025 | +7.9% |
| Sep 2025 | +10.6% |
| Jun 2025 | +8.0% |
| Mar 2025 | +7.6% |
| Dec 2024 | +0.6% |
| Sep 2024 | +7.8% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.3B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CNA
| FY Dec 2025 | $2.4B |
| FY Dec 2024 | $2.5B |
| FY Dec 2023 | $2.2B |
| FY Dec 2022 | $2.5B |
| FY Dec 2021 | $2.0B |
| Jun 2026 | $629.0M |
| Mar 2026 | $380.0M |
| Dec 2025 | $542.0M |
| Sep 2025 | $704.0M |
| Jun 2025 | $538.0M |
| Mar 2025 | $620.0M |
| Dec 2024 | $665.0M |
| Sep 2024 | $730.0M |
At each fiscal year end
Single quarter
Debt to equity
0.31x
long-term 2026-06-30 plus current 2025-09-30 (9 months older than the period end); equity 2026-06-30
Debt to equity CNA
| FY Dec 2025 | 0.30x |
| FY Dec 2024 | 0.28x |
| FY Dec 2023 | 0.31x |
| FY Dec 2022 | 0.33x |
| FY Dec 2021 | 0.25x |
| Jun 2026 | 0.31x |
| Mar 2026 | 0.32x |
| Dec 2025 | 0.30x |
| Sep 2025 | 0.31x |
| Jun 2025 | 0.28x |
| Mar 2025 | 0.29x |
| Dec 2024 | 0.28x |
| Sep 2024 | 0.28x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.67x
TTM operating cash flow over long-term 2026-06-30 plus current 2025-09-30 (9 months older than the period end)
Cash flow to debt CNA
| FY Dec 2025 | 0.72x |
| FY Dec 2024 | 0.86x |
| FY Dec 2023 | 0.75x |
| FY Dec 2022 | 0.90x |
| FY Dec 2021 | 0.72x |
| Jun 2026 | 0.67x |
| Mar 2026 | 0.65x |
| Dec 2025 | 0.72x |
| Sep 2025 | 0.76x |
| Jun 2025 | 0.89x |
| Mar 2025 | 0.91x |
| Dec 2024 | 0.86x |
| Sep 2024 | 0.80x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+11.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CNA
| FY Dec 2025 | +11.5% |
| FY Dec 2024 | +9.4% |
| FY Dec 2023 | +13.1% |
| FY Dec 2022 | +6.9% |
| FY Dec 2021 | +9.9% |
| Jun 2026 | +11.3% |
| Mar 2026 | +11.5% |
| Dec 2025 | +11.5% |
| Sep 2025 | +9.0% |
| Jun 2025 | +8.5% |
| Mar 2025 | +9.0% |
| Dec 2024 | +9.4% |
| Sep 2024 | +13.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CNA
| FY Dec 2025 | +1.9% |
| FY Dec 2024 | +1.5% |
| FY Dec 2023 | +1.9% |
| FY Dec 2022 | +1.1% |
| FY Dec 2021 | +1.8% |
| Jun 2026 | +1.8% |
| Mar 2026 | +1.8% |
| Dec 2025 | +1.9% |
| Sep 2025 | +1.5% |
| Jun 2025 | +1.3% |
| Mar 2025 | +1.4% |
| Dec 2024 | +1.5% |
| Sep 2024 | +2.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CNA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CNA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.65x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CNA
| FY Dec 2025 | 10.18x |
| FY Dec 2024 | 13.70x |
| FY Dec 2023 | 9.55x |
| FY Dec 2022 | 16.98x |
| FY Dec 2021 | 10.16x |
| Jun 2026 | 10.68x |
| Mar 2026 | 10.27x |
| Dec 2025 | 10.18x |
| Sep 2025 | 12.69x |
| Jun 2025 | 14.45x |
| Mar 2025 | 15.44x |
| Dec 2024 | 13.70x |
| Sep 2024 | 10.20x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value CNA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+17.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield CNA
| FY Dec 2025 | +18.6% |
| FY Dec 2024 | +18.9% |
| FY Dec 2023 | +19.2% |
| FY Dec 2022 | +21.4% |
| FY Dec 2021 | +16.5% |
| Jun 2026 | +17.1% |
| Mar 2026 | +17.4% |
| Dec 2025 | +18.6% |
| Sep 2025 | +20.1% |
| Jun 2025 | +20.3% |
| Mar 2025 | +19.0% |
| Dec 2024 | +18.9% |
| Sep 2024 | +17.4% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.26x
P/E over trailing EPS growth of 41%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CNA
| FY Dec 2025 | 0.31x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 0.12x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.14x |
| Jun 2026 | 0.26x |
| Mar 2026 | 0.29x |
| Dec 2025 | 0.31x |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | 0.47x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2023-06 | |
|---|---|---|---|---|
| Revenue | $15.0B | $14.3B | $13.3B | n/a |
| Net income | $1.3B | $959.0M | $1.2B | n/a |
| EPS (diluted) | 4.69 | 3.52 | 4.43 | n/a |
| Operating cash flow | $2.5B | $2.6B | $2.3B | n/a |
| Long-term debt | $3.0B | $3.0B | $2.5B | $2.4B |
| Buybacks | $34.0M | $20.0M | $24.0M | n/a |
| Dividends paid | $1.0B | $1.0B | $787.0M | n/a |
SEC XBRL, fiscal years, as known on 2026-10-28
CNA Stock Sonar score 5/7 axes
Find similar shapesCompareCNA ranks highest on financial health (50th percentile) and profitability (36th), and lowest on growth (14th), among Insurance peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CNA filings, in plain words
Are CNA Financial insiders buying or selling CNA?
In the 180 days to 2026-10-28, CNA Financial insiders were net sellers, a net $1.6M across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of CNA?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $1.6M of stock; the latest, by DANIEL FRANZETTI, was filed 2026-08-04.
Read the full summary
In the 180 days to 2026-10-28, CNA Financial insiders were net sellers of CNA, a net $1.6M across purchases and sales reported on Form 4 by 2 sellers. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $1.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
